Flegatusin syrup 115 ml

Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature

Compositum

Zakłady Farmaceutyczne Polpharma S.A.

Zakłady Farmaceutyczne Polpharma S.A.,
street Pelplińska 19,
83-200 Starogard Gdański,
EN

The product should not be used in people with active gastric ulcer - the product may worsen the symptoms of the disease. When using the product in people with bronchial asthma, special caution should be exercised. In case of liver or kidney failure, metabolites of bromhexine hydrochloride may accumulate in these organs. If shortness of breath, fever and purulent sputum occur during use, consult a doctor or other qualified health care professional. Cases of serious skin reactions such as erythema multiforme, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and acute generalized exanthematous pustulosis have been reported ,AGEP) associated with the use of bromhexine hydrochloride. Additionally, during the early stages of Stevens-Johnson syndrome or TEN, you may initially experience flu-like symptoms such as fever, muscle aches, rhinitis, cough and sore throat. The patient may be misled by the appearance of non-specific flu-like symptoms and begin symptomatic treatment of cough and cold. If signs and symptoms of progressive skin rash (sometimes associated with blistering or mucosal lesions) occur, treatment with bromhexine hydrochloride should be discontinued immediately and the patient should be consulted. The product contains 4 g of sucrose in 5 ml of syrup (8 g of sucrose in 10 ml of syrup, 12 g of sucrose in 15 ml of syrup, 24 g of sucrose in 30 ml of syrup). Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or the sucrase-isomaltase insufficiency should not take this medicinal product. This should be taken into account in patients with diabetes. The product contains 6.6 mg of sodium benzoate in 5 ml of syrup (13.2 mg of sodium benzoate in 10 ml of syrup, 19.8 mg of sodium benzoate in 15 ml, 39.6 mg of sodium benzoate in 30 ml of syrup). The product contains less than 1 mmol (23 mg) sodium per 10 ml of syrup, i.e. the product is essentially 'sodium-free'. This medicinal product contains 1.7 mg of alcohol (ethanol) in every 5 ml of syrup (3.5 mg of alcohol (ethanol) in 10 ml of syrup, 5.2 mg of alcohol (ethanol) in 15 ml, 10.3 mg of alcohol (ethanol) in 30 ml of syrup). The alcohol quantity of this product is equivalent to less than 1ml beer or 1ml wine per 5ml/10ml/15ml/30ml syrup. The small amount of alcohol in this product will not cause any noticeable effects.